Intestinal Ischemia-Reperfusion Injury and Calcium Channel Blockers: Getting to the Core of the Problem
- 27 January 2020
- journal article
- editorial
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 34 (7) , 808-809
Abstract
(2020). Intestinal Ischemia-Reperfusion Injury and Calcium Channel Blockers: Getting to the Core of the Problem. Journal of Investigative Surgery. Ahead of Print.Keywords
This publication has 10 references indexed in Scilit:
- Combination Therapy of Allopurinol and Dantrolene and Its Role In The Prevention of Experimental Ischemia Reperfusion Injury Of The Small IntestineJournal of Investigative Surgery, 2020
- Functional recovery after dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart modelPLOS ONE, 2018
- Silibinin Effect on Fas/FasL, HMGB1, and CD45 Expressions in a Rat Model Subjected to Liver Ischemia-Reperfusion InjuryJournal of Investigative Surgery, 2017
- Antiarrhythmic effects of dantrolene in human diseased cardiomyocytesHeart Rhythm, 2017
- Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injuryJournal of Physiology and Biochemistry, 2016
- Effects of Dantrolene on Ischemia-Reperfusion Injury in Animal Models: A Review of Outcomes in Heart, Brain, Liver, and KidneyJournal of Investigative Medicine, 2010
- The Cytoprotective Effects of DantroleneAnesthesia & Analgesia, 2010
- Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in ratsSurgery, 2007
- Beneficial Effects of Verapamil on Intestinal Ischemia and Reperfusion Injury: Pretreatment versus Postischemic TreatmentEuropean Surgical Research, 1998
- Role of Diltiazem in Ischemia-Reperfusion Injury of the IntestineEuropean Surgical Research, 1994